plicamycin has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, S; Li, Y; Liu, F; Liu, H; Liu, J; Wang, H; Wang, L; Wu, N; Zhang, J; Zhang, X; Zhang, Y | 1 |
| Ammanamanchi, S; Rogge, J; Thangasamy, A | 1 |
2 other study(ies) available for plicamycin and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Erb‑B2 Receptor Tyrosine Kinase 2 is negatively regulated by the p53‑responsive microRNA‑3184‑5p in cervical cancer cells.
Topics: Adult; Aged; Biopsy; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cervix Uteri; Class I Phosphatidylinositol 3-Kinases; Female; Gene Expression Regulation, Neoplastic; Humans; Hysterectomy; MicroRNAs; Middle Aged; Neoplasm Invasiveness; Plicamycin; Receptor, ErbB-2; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2021 |
Regulation of RON tyrosine kinase-mediated invasion of breast cancer cells.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Drosophila; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Neoplasm Invasiveness; Neoplasm Proteins; Plicamycin; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Response Elements; RNA, Small Interfering; Sp1 Transcription Factor | 2008 |